EOMES and neoplasm: TGF-beta in the TME is responsible for the hypo-expression of eomesodermin (EOMES) (137), crucial for NK cell development and cytotoxicity (138, 139), and reprograms anti-tumor ILC3s to pro-tumor regulatory ILC3s (ILCregs) that release IL-10 (140).